Small Pharma Inc. (CVE:DMT – Get Rating)’s stock price shot up 7.1% during trading on Wednesday . The company traded as high as C$0.08 and last traded at C$0.08. 102,000 shares were traded during trading, a decline of 57% from the average session volume of 239,262 shares. The stock had previously closed at C$0.07.
Small Pharma Price Performance
The firm has a market capitalization of C$28.94 million, a PE ratio of -1.13 and a beta of 1.97. The company has a 50-day moving average price of C$0.07 and a 200 day moving average price of C$0.10.
About Small Pharma
Small Pharma Inc, a biotechnology company, focuses on developing short-acting psychedelics with therapy for the treatment of mental health conditions. Its clinical program is N,N-dimethyltryptamine assisted therapy to treat major depressive disorder. The company's product includes SPL026 Placebo, which is in clinical Phase IIA for the treatment of major depressive disorder.
See Also
- It’s Time To Take Another Bite Of Take-Two Interactive
- Zoetis Declares New Dividend, Hinting At Undervaluation
- Good News For Walmart Isn’t So Great For Everybody Else
- Eagle Materials, Answering America’s Building Supply Needs
- Pharma Giants Novartis, Lilly, Merck, and Novo Outperform Market
Receive News & Ratings for Small Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Small Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
